Your browser doesn't support javascript.
loading
Rapid synchronous type 1 IFN and virus-specific T cell responses characterize first wave non-severe SARS-CoV-2 infections.
Chandran, Aneesh; Rosenheim, Joshua; Nageswaran, Gayathri; Swadling, Leo; Pollara, Gabriele; Gupta, Rishi K; Burton, Alice R; Guerra-Assunção, José Afonso; Woolston, Annemarie; Ronel, Tahel; Pade, Corinna; Gibbons, Joseph M; Sanz-Magallon Duque De Estrada, Blanca; Robert de Massy, Marc; Whelan, Matthew; Semper, Amanda; Brooks, Tim; Altmann, Daniel M; Boyton, Rosemary J; McKnight, Áine; Captur, Gabriella; Manisty, Charlotte; Treibel, Thomas Alexander; Moon, James C; Tomlinson, Gillian S; Maini, Mala K; Chain, Benjamin M; Noursadeghi, Mahdad.
Afiliação
  • Chandran A; Division of Infection and Immunity, University College London, London WC1E 6BT, UK.
  • Rosenheim J; Division of Infection and Immunity, University College London, London WC1E 6BT, UK.
  • Nageswaran G; Division of Infection and Immunity, University College London, London WC1E 6BT, UK.
  • Swadling L; Division of Infection and Immunity, University College London, London WC1E 6BT, UK.
  • Pollara G; Division of Infection and Immunity, University College London, London WC1E 6BT, UK.
  • Gupta RK; Institute for Global Health, University College London, London WC1E 6BT, UK.
  • Burton AR; Division of Infection and Immunity, University College London, London WC1E 6BT, UK.
  • Guerra-Assunção JA; Division of Infection and Immunity, University College London, London WC1E 6BT, UK.
  • Woolston A; Division of Infection and Immunity, University College London, London WC1E 6BT, UK.
  • Ronel T; Division of Infection and Immunity, University College London, London WC1E 6BT, UK.
  • Pade C; Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 4NS, UK.
  • Gibbons JM; Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 4NS, UK.
  • Sanz-Magallon Duque De Estrada B; Division of Infection and Immunity, University College London, London WC1E 6BT, UK.
  • Robert de Massy M; Division of Infection and Immunity, University College London, London WC1E 6BT, UK.
  • Whelan M; Division of Infection and Immunity, University College London, London WC1E 6BT, UK.
  • Semper A; National Infection Service, Public Health England, Porton Down, Salisbury SP4 0JQ, UK.
  • Brooks T; National Infection Service, Public Health England, Porton Down, Salisbury SP4 0JQ, UK.
  • Altmann DM; Department of Immunology and Inflammation, Imperial College London, London SW7 2BX, UK.
  • Boyton RJ; Department of Infectious Disease, Imperial College London, London SW7 2BX, UK.
  • McKnight Á; Lung Division, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Captur G; Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 4NS, UK.
  • Manisty C; Institute of Cardiovascular Sciences, University College London, London WC1E 6BT, UK.
  • Treibel TA; MRC Unit for Lifelong Health and Ageing, University College London, London WC1E 6BT, UK.
  • Moon JC; Institute of Cardiovascular Sciences, University College London, London WC1E 6BT, UK.
  • Tomlinson GS; Institute of Cardiovascular Sciences, University College London, London WC1E 6BT, UK.
  • Maini MK; Institute of Cardiovascular Sciences, University College London, London WC1E 6BT, UK.
  • Chain BM; Division of Infection and Immunity, University College London, London WC1E 6BT, UK.
  • Noursadeghi M; Division of Infection and Immunity, University College London, London WC1E 6BT, UK.
Cell Rep Med ; 3(3): 100557, 2022 03 15.
Article em En | MEDLINE | ID: mdl-35474751

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interferon Tipo I / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interferon Tipo I / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article